A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 31 July 2019 |
| Author/s |
author: Philippe L. Bedard Cristina Saura Vandana G Abramson |
| Publication date | July 31, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |